• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG GAV W.DISTAL CATH.10/40; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG GAV W.DISTAL CATH.10/40; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV320T
Device Problem Partial Blockage (1065)
Patient Problem Hydrocephalus (3272)
Event Date 03/13/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Patient data - height 180 cm.Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that a gav valve was possibly blocked.A patient underwent a retro-auricular shunt system implantation on (b)(6) 2018.Sometime later, underdrainage was noted; and the patient's cerebrospinal fluid (csf) protein count was also observed to be high.On (b)(6) 2019, the shunt was replaced due to this malfunction.Further details were not available.
 
Manufacturer Narrative
Aesculap inc.(importer, registration no.2916714) is submitting this report on behalf of christoph miethke gmbh & co.Kg (manufacturer, registration no.3004721439).Exemption number: e2017044 manufacturing site evaluation: visual inspection - no significant deformations or damage of the valve were detected during inspection.It was noted during observation that the catheter was not securely attached to the valve.Permeability test- the test has indicated that the valve has a blockage.Adjustment test and braking force/function - this is a fixed pressure valve.These tests are not applicable.Results - after the above tests, we have dismantled the valve.Inside the valve we have found a build-up of substances (likely protein).We were unable to closely investigate the claim of over-drainage because the valve is not permeable, and therefore a computer-controlled test was not possible.Based on our investigation, we confirm the presence of occlusion in the valve, likely due to deposits observed inside the valve.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GAV W.DISTAL CATH.10/40
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8487802
MDR Text Key141071367
Report Number3004721439-2019-00082
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K031303
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/04/2023
Device Model NumberFV320T
Device Catalogue NumberFV320T
Device Lot Number20038426
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/15/2019
Distributor Facility Aware Date04/04/2019
Date Manufacturer Received04/04/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient Weight90
-
-